Trademark Overview
On Tuesday, July 15, 2025, a trademark application was filed for NOVADERM with the United States Patent and Trademark Office. The USPTO has given the NOVADERM trademark a serial number of 99285059. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, July 15, 2025. This trademark is owned by Regenicin, Inc.. The NOVADERM trademark is filed in the Pharmaceutical Products category with the following description:
Regenerative cell therapy products, namely, cultured skin grafts for wound and burn treatment, wherein skin grafts are grown from autologous, allogeneic, or other skin cells, and are designed to avoid immunological rejection or elimination following transplantation